Related Experiment Videos
Silastic catheters for home antibiotic therapy in patients with cystic fibrosis
Unlabelled:
Repeated 14-day courses of intravenous antibiotic therapy for patients with cystic fibrosis (CF), who have been colonized with Pseudomonas aeruginosa (PA), is one currently accepted treatment. Conventional intravenous cannulas for antibiotic delivery often have a short line life leading to frequent venipunctures. Therefore we used silastic catheters as a peripheral venous access. Silastic catheters (15 cm, 0.6 mm diameter) were inserted 10 cm into a cubital vein in 15 patients with CF (age 5-32 years) for 20 antibiotic courses. After the antibiotic infusion the catheter was flushed with 200 U heparin (2 ml Vetren). In all patients the antibiotic therapy was delivered as a home therapy. In 15 antibiotic courses the silastic catheter could be continuously used for 14 days. One patient with methicillin resistant Staphylococcus aureus received antibiotic therapy for 54 consecutive days using the same silastic catheter. The catheter had to be removed in four courses: once because of thrombophlebitis with local inflammation, once because of burning pain during infusion and occlusion twice. In one case the patient removed his catheter because of technical problems. No other serious side effects occurred. Ten patients had previously received intravenous antibiotics at least once. The median line life of the last used conventional peripheral cannula of all patients was 4 days versus 14 days with the use of the silastic catheter (P < 0.005). All patients preferred the silastic catheter to other venous access.
Conclusion:
Because of the long line life and easy handling, silastic catheters may be an alternative venous access to perform home antibiotic therapy in patients with CF.
Insights
Silastic catheters offer a superior venous access for cystic fibrosis patients undergoing home antibiotic therapy, lasting significantly longer than conventional cannulas. This method improves patient comfort and treatment adherence.
Area of Science:
- Medical Devices
- Infectious Diseases
- Pulmonology
Background:
- Cystic Fibrosis (CF) patients often require repeated intravenous antibiotic courses for Pseudomonas aeruginosa (PA) colonization.
- Conventional peripheral cannulas have a limited lifespan, necessitating frequent venipunctures for antibiotic delivery.
- Home-based antibiotic therapy is a common treatment modality for CF patients.
Purpose of the Study:
- To evaluate the efficacy and usability of silastic catheters as a peripheral venous access device for home antibiotic therapy in cystic fibrosis patients.
- To compare the line life of silastic catheters with conventional peripheral cannulas in this patient population.
Main Methods:
- Silastic catheters (15 cm) were inserted into the cubital vein of 15 CF patients (age 5-32) for antibiotic administration.
- Catheters were flushed with heparin after infusions and used for home therapy.
- Line life, side effects, and patient preference were recorded and compared to previous conventional cannula use.
Main Results:
- Silastic catheters achieved a median line life of 14 days, significantly longer than the 4-day median for conventional cannulas (P < 0.005).
- Catheters were successfully used for the full 14-day course in 15 out of 20 antibiotic courses.
- One patient utilized the same catheter for 54 days for methicillin-resistant Staphylococcus aureus treatment.
- Minor complications included thrombophlebitis, burning pain, and occlusion; all patients preferred silastic catheters.
Conclusions:
- Silastic catheters provide a durable and user-friendly alternative for venous access in cystic fibrosis patients receiving home antibiotic therapy.
- The extended line life and patient preference suggest silastic catheters can improve the management of chronic infections in CF.